1. Home
  2. OCGN vs COE Comparison

OCGN vs COE Comparison

Compare OCGN & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • COE
  • Stock Information
  • Founded
  • OCGN 2013
  • COE 2011
  • Country
  • OCGN United States
  • COE Singapore
  • Employees
  • OCGN N/A
  • COE N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • COE Other Consumer Services
  • Sector
  • OCGN Health Care
  • COE Real Estate
  • Exchange
  • OCGN Nasdaq
  • COE Nasdaq
  • Market Cap
  • OCGN 321.7M
  • COE 271.9M
  • IPO Year
  • OCGN N/A
  • COE 2016
  • Fundamental
  • Price
  • OCGN $1.79
  • COE N/A
  • Analyst Decision
  • OCGN Strong Buy
  • COE
  • Analyst Count
  • OCGN 3
  • COE 0
  • Target Price
  • OCGN $6.00
  • COE N/A
  • AVG Volume (30 Days)
  • OCGN 7.9M
  • COE 10.4K
  • Earning Date
  • OCGN 11-07-2025
  • COE 09-03-2025
  • Dividend Yield
  • OCGN N/A
  • COE N/A
  • EPS Growth
  • OCGN N/A
  • COE N/A
  • EPS
  • OCGN N/A
  • COE N/A
  • Revenue
  • OCGN $4,754,000.00
  • COE $68,928,000.00
  • Revenue This Year
  • OCGN N/A
  • COE N/A
  • Revenue Next Year
  • OCGN N/A
  • COE N/A
  • P/E Ratio
  • OCGN N/A
  • COE N/A
  • Revenue Growth
  • OCGN N/A
  • COE 93.05
  • 52 Week Low
  • OCGN $0.52
  • COE $12.98
  • 52 Week High
  • OCGN $1.90
  • COE $51.71
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 70.01
  • COE 42.62
  • Support Level
  • OCGN $1.31
  • COE $40.13
  • Resistance Level
  • OCGN $1.85
  • COE $44.73
  • Average True Range (ATR)
  • OCGN 0.14
  • COE 1.17
  • MACD
  • OCGN 0.02
  • COE -1.01
  • Stochastic Oscillator
  • OCGN 78.81
  • COE 6.18

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About COE 51Talk Online Education Group

51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.

Share on Social Networks: